<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Hungerford J</submitter><funding>Horace H. Rackham School of Graduate Studies, University of Michigan</funding><funding>Hermann Frasch Foundation</funding><funding>Pharmaceutical Research and Manufacturers of America Foundation</funding><funding>New Mexico Department of Agriculture</funding><funding>National Institute of General Medical Sciences</funding><funding>NIGMS NIH HHS</funding><pubmed_abstract>Cyclopeptide alkaloids are an expanding class of plant peptide natural products defined by a macrocyclic ether cross-link via a tyrosine-derived phenol. Classical cyclopeptide alkaloids are characterized by strained 13- to 15-membered cyclophanes and terminal modifications such as &lt;i>N&lt;/i>-methylation and C-terminal styrylamine moieties. While synthetic access to many classical cyclopeptide alkaloids has been established, no biosynthetic route has been reported. Here, we elucidate the biosynthetic pathway of a 14-membered cyclopeptide alkaloid, lotusine A, from the Chinese date tree (&lt;i>Ziziphus jujuba&lt;/i>), which features peptide cyclization on a ribosomal precursor peptide by a split burpitide cyclase, nonheme-iron and 2-oxoglutarate-dependent oxidative decarboxylation affording the C-te</pubmed_abstract><journal>Journal of the American Chemical Society</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12927610</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Biosynthesis of 14-Membered Cyclopeptide Alkaloids via Nonheme Iron- and 2-Oxoglutarate-Dependent Oxidative Decarboxylation.</pubmed_title><pmcid>PMC12927610</pmcid><funding_grant_id>T32GM140223</funding_grant_id><funding_grant_id>F32 GM146395</funding_grant_id><funding_grant_id>R35GM146934</funding_grant_id><funding_grant_id>R35 GM146934</funding_grant_id><funding_grant_id>F32GM146395</funding_grant_id><funding_grant_id>T32 GM140223</funding_grant_id><funding_grant_id>F31 GM155959</funding_grant_id><funding_grant_id>F31GM155959</funding_grant_id><pubmed_authors>Li W</pubmed_authors><pubmed_authors>Shafiq K</pubmed_authors><pubmed_authors>Mydy LS</pubmed_authors><pubmed_authors>Mendoza-Perez L</pubmed_authors><pubmed_authors>May G</pubmed_authors><pubmed_authors>Chigumba DN</pubmed_authors><pubmed_authors>Hungerford J</pubmed_authors><pubmed_authors>Yao S</pubmed_authors><pubmed_authors>Kersten RD</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>McDonough KM</pubmed_authors><pubmed_authors>Ousley DA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Biosynthesis of 14-Membered Cyclopeptide Alkaloids via Nonheme Iron- and 2-Oxoglutarate-Dependent Oxidative Decarboxylation.</name><description>Cyclopeptide alkaloids are an expanding class of plant peptide natural products defined by a macrocyclic ether cross-link via a tyrosine-derived phenol. Classical cyclopeptide alkaloids are characterized by strained 13- to 15-membered cyclophanes and terminal modifications such as &lt;i>N&lt;/i>-methylation and C-terminal styrylamine moieties. While synthetic access to many classical cyclopeptide alkaloids has been established, no biosynthetic route has been reported. Here, we elucidate the biosynthetic pathway of a 14-membered cyclopeptide alkaloid, lotusine A, from the Chinese date tree (&lt;i>Ziziphus jujuba&lt;/i>), which features peptide cyclization on a ribosomal precursor peptide by a split burpitide cyclase, nonheme-iron and 2-oxoglutarate-dependent oxidative decarboxylation affording the C-te</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-07-16T17:48:26.936Z</modification><creation>2026-07-09T11:10:07.068Z</creation></dates><accession>S-EPMC12927610</accession><cross_references><pubmed>41698050</pubmed><doi>10.1021/jacs.5c23400</doi></cross_references></HashMap>